Stephen D. Goble

Discovery of Vibegron: A Potent and Selective β₃Adrenergic Receptor Agonist for the Treatment of Overactive Bladder

Scott D. Edmondson, Cheng Zhu, Nam Fung Kar et al. · Journal of Medicinal Chemistry · 2015 · 101 citations · Full text

Microscale High-Throughput Experimentation as an Enabling Technology in Drug Discovery: Application in the Discovery of (Piperidinyl)pyridinyl-1 <i>H</i> -benzimidazole Diacylglycerol Acyltransferase 1 Inhibitors

Tim Cernak, Nathan J. Gesmundo, Kevin D. Dykstra et al. · Journal of Medicinal Chemistry · 2017 · 81 citations · Full text

Ruthenium-Catalyzed Carboxylative Cyclization of 1,6-Diynes

Hahn Kim, Stephen D. Goble, Chulbom Lee · Journal of the American Chemical Society · 2007 · 36 citations

Engineering, Alkene Metathesis, Single Ruthenium +9

Discovery of a Potent and Orally Bioavailable CCR2 and CCR5 Dual Antagonist

Alexander Pasternak, Stephen D. Goble, Mary Struthers et al. · ACS Medicinal Chemistry Letters · 2009 · 34 citations · Full text

Medicinal Chemistry, Pharmaceutical Science, Biochemistry +12

Design, synthesis, and structure–activity relationship of novel CCR2 antagonists

Shankaran Kothandaraman, Karla L. Donnely, Gabor Butora et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 25 citations · Full text

Molecular Pharmacology, Medicine, Non-peptide Ligand +3